WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/24/2022
Back to search
Official data from USPTO
EMINENCE CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
10/25/2022
Classification
Registered
Trademark type
Combined
Nice classes
35, 41
Filing date
09/22/2009
Registration date
01/11/2011
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2021
Last transaction
10/25/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/22/2009
First use in commerce
05/19/2010
Drawing code
3
Owner type
03
Owner location
Colorado Springs, CO, US
Examiner
AIKENS, RONALD E
Law office
M30
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word "EMINENCE" with an oversize, stylized letter "M", wherein the peaks of the letter "M" extend above the other letters and the valley of the letter "M" extends below the other letters, further wherein a stylized sun with rays emanating therefrom is in the valley of the letter "M" an underscore beginning below the right peak of the letter "M" in the word "EMINENCE" and ending at the end of the word; and the words "CLINICAL RESEARCH" in a row and below the underscore.
Holders and representatives
Holders
Eminence Clinical Research, Inc.
Eminence Clinical Research, Inc.
Representatives
Eminence Clinical Research, Inc.
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical trials and applications for device approval
Class 41
training medical personnel on the conduct of medical device studies
Publications
History of USPTO decisions and trademark events.
42 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/24/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/09/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/09/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/09/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/08/2021
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/08/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/08/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
12/23/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/15/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/13/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/13/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/13/2017
E815
TEAS SECTION 8 & 15 RECEIVED
01/10/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/07/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/06/2010
ALIE
ASSIGNED TO LIE
12/06/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/12/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/08/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/08/2010
IUAF
USE AMENDMENT FILED
10/25/2010
EISU
TEAS STATEMENT OF USE RECEIVED
10/25/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/11/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2010
PUBO
PUBLISHED FOR OPPOSITION
02/16/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2010
ALIE
ASSIGNED TO LIE
01/12/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2009
GNRT
NON-FINAL ACTION E-MAILED
12/19/2009
CNRT
NON-FINAL ACTION WRITTEN
12/19/2009
DOCK
ASSIGNED TO EXAMINER
12/18/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/19/2009
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
09/26/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/25/2009
NWAP
NEW APPLICATION ENTERED
09/25/2009
Continuous trademark protection
Get notified about every new filing that threatens EMINENCE CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.